Abstract
Objective
To determine the effect of perinatal and neonatal risk factors on retinopathy of prematurity (ROP) and to examine the association of fertility treatments on the risk for ROP in very low birth weight (VLBW) preterm twins.
Methods
The population-based observational study consisted of VLBW twins born at 24–29 weeks gestational age (GA). Data from the Israel national database (1995–2020) were applied. Univariate and multivariable logistic regression using the General Estimating Equation were used for assessment of risk factors.
Results
The study population comprised 4092 infants of whom 2374 (58%) were conceived following fertility treatments. ROP was diagnosed in 851 (20.8%) infants. The odds for ROP approximately doubled with each week decrease in GA: at 24 weeks, Odds Ratio (OR) 58.00 (95% confidence interval (CI) 31.83–105.68); 25 weeks, OR 25.88 (95% CI 16.76–39.96); 26 weeks, OR 12.69 (95% CI 8.84–18.22) compared to 29 weeks GA. Each decrease in one birthweight z-score was associated with 1.82-fold increased risk for ROP (OR, 1.82, 95% CI 1.59–2.08). Infertility treatments were not associated with ROP. Neonatal morbidities significantly associated with ROP were surgical necrotizing enterocolitis (NEC) (OR, 2.04, 95% CI 1.31–3.19); surgically treated patent ductus arteriosus (PDA) (OR, 1.63, 95% CI 1.12–2.37); sepsis (OR, 1.43, 95% CI 1.20–1.71) and bronchopulmonary dysplasia (OR, 1.52, 95% CI 1.22–1.90).
Conclusion
Among preterm VLBW twins, poor intrauterine growth and surgical interventions for NEC and PDA were associated with high odds for ROP. This study does not support an association of fertility treatments with increased risk for ROP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
American Academy of Pediatrics Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131:189–95.
Friling R, Rosen SD, Monos T, Karplus M, Yassur Y. Retinopathy of prematurity in multiple-gestation, very low birth weight infants. J Pediatr Ophthalmol Strabismus. 1997;34:96–100.
Blumenfeld LC, Siatkowski RM, Johnson RA, Feuer WJ, Flynn JT. Retinopathy of prematurity in multiple-gestation pregnancies. Am J Ophthalmol. 1998;125:197–203.
Azad R, Chandra P, Patwardhan SD, Gupta A. Profile of asymmetrical retinopathy of prematurity in twins. Indian J Ophthalmol. 2010;58:209.
Wang ZH, Li YY, Liu ZM. Birth weight and gestational age on retinopathy of prematurity in discordant twins in China. Int J Ophthalmol. 2014;7:663.
Watts P, Adams GG. In vitro fertilization and stage 3 retinopathy of prematurity. Eye. 2000;14:330–3.
Friling R, Axer-Siegel R, Hersocovici Z, Weinberger D, Sirota L, Snir M. Retinopathy of prematurity in assisted versus natural conception and singleton versus multiple births. Ophthalmology. 2007;114:321–4.
Han G, Lim DH, Kang D, Cho J, Guallar E, Chang YS, et al. Association between retinopathy of prematurity in very-low-birth-weight infants and neurodevelopmental impairment. Am J Ophthalmol. 2022;244:205–15.
Riskin A, Riskin-Mashiah S, Lusky A, Reichman B, Israel Neonatal Network. The relationship between delivery mode and mortality in very low birthweight singleton vertex-presenting infants. BJOG. 2004;111:1365–71.
Grisaru-Granovsky S, Reichman B, Lerner-Geva L, Boyko V, Hammerman C, Samueloff A, et al. Population-based trends in mortality and neonatal morbidities among singleton, very preterm, very low birth weight infants over 16 years. Early Hum Dev. 2014;90:821–7.
Kramer MS, Platt RW, Wen S, Joseph KS, Allen A, Abrahamowicz M, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108:E35.
International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123:991–9.
An International Classification of Retinopathy of Prematurity. The committee for the classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102:1130–4.
Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. One-year outcome–structure and function. Cryotherapy for retinopathy of prematurity cooperative group. Arch Ophthalmol. 1990;108:1408–16.
Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233–50.
Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Chan RP, Berrocal A, et al. International classification of retinopathy of prematurity. Ophthalmology 2021;128.
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.
Chmielarz-Czarnocińska A, Pawlak M, Szpecht D, Choręziak A, Szymankiewicz-Bręborowicz M, Gotz-Więckowska A. Management of retinopathy of prematurity (ROP) in a Polish cohort of infants. Sci Rep. 2021;11:1–8.
Van Sorge AJ, Termote JUM, Simonsz HJ, Kerkhoff FT, Van Rijn LJ, Lemmens W, et al. Outcome and quality of screening in a nationwide survey on retinopathy of prematurity in The Netherlands. Br J Ophthalmol. 2014;98:1056–60.
Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, et al. Incidence and early course of retinopathy of prematurity: secondary analysis of the postnatal growth and retinopathy of prematurity (G-ROP) study. JAMA Ophthalmol. 2018;136:1383–9.
Watts P, Adams GGW. In vitro fertilisation and stage 3 retinopathy of prematurity. Eye. 2000;14:330–3.
Enomoto H, Miki A, Matsumiya W, Honda S. Evaluation of oxygen supplementation status as a risk factor associated with the development of severe retinopathy of prematurity. Ophthalmologica. 2015;234:135–8.
Alajbegovic-Halimic J, Zvizdic D, Alimanovic-Halilovic E, Dodik I, Duvnjak S. Risk factors for retinopathy of prematurity in premature born children. Med Arch. 2015;69:409–13.
Rasoulinejad SA, Montazeri M. Retinopathy of prematurity in neonates and its risk factors: a seven year study in Northern Iran. Open Ophthalmol J. 2016;10:17–21.
Ying GS, VanderVeen D, Daniel E, Quinn GE, Baumritter A. Risk score for predicting treatment-requiring retinopathy of prematurity (ROP) in the telemedicine approaches to evaluating acute-phase ROP study. Ophthalmology. 2016;123:2176–82.
Zloto O, Goldfinger LM, Mazkereth R, Spierer A, Yinon Y. Retinopathy of prematurity in discordant twins: is the small twin at increased risk? Graefe’s Arch Clin Exp Ophthalmol. 2020;258:893–8.
Spekman JA, Emrani SEI, Schalij-Delfos NE, Slaghekke F, van Klink JMM, Lopriore E, et al. Association between fetal growth-restriction and retinopathy of prematurity using a unique identical twin model. Pediatr Res. 2023:1–6.
Janssen PA, Thiessen P, Klein MC, Whitfield MF, MacNab YC, Cullis-Kuhl SC. Standards for the measurement of birth weight, length and head circumference at term in neonates of European, Chinese and South Asian ancestry. Open Med. 2007;1:e74.
Barker L, Bunce C, Husain S, Adams GG. Is artificial reproductive technology a risk factor for retinopathy of prematurity independent of the generation of multiple births? Eur J Ophthalmol. 2017;27:174–8.
Minasian M, Fielder A. IVF babies with ROP at higher gestational age and birth weight: implications of changing screening criteria. Br J Ophthalmol. 2005;89:1066.
Chan RV, Yonekawa Y, Morrison MA, Sun G, Wong RK, Perlman JM, et al. Association between assisted reproductive technology and advanced retinopathy of prematurity. Clin Ophthalmol. 2010;4:1385–90.
Tsumi E, Lavy Y, Sheiner E, Barrett C, Harlev A, Bal MH, et al. Assisted reproductive technology and long-term ophthalmic morbidity of the offspring. J Dev Origins Health Dis. 2021;12:627–31.
Gao L, Shao W, Li N, Tian C, Jia H, Peng X, et al. The risk of retinopathy of prematurity in the infants following assisted reproductive technology: a meta-analysis. Biomed Res Int. 2019:1–11.
Wikstrand MH, Strömland K, Flodin S, Bergh C, Wennerholm UB, Hellström A. Ophthalmological findings in children born after intracytoplasmic sperm injection. Acta Ophthalmol Scand. 2005;84:177–81.
Shenhav‐Goldberg R, Brym R, Lenton‐Brym T. Family welfare effort, total fertility, and in vitro fertilization: explaining the israeli anomaly. Can Rev Sociol/Revue Can Sociol. 2019;56:421–38.
Funnell CL, Dabbs TR. Assisted conception and retinopathy of prematurity: 8-year follow-up study. Eye. 2007;21:383–6.
Fundora JB, Binenbaum G, Tomlinson L, Yu Y, Ying GS, Maheshwari A, et al. Association of surgical necrotizing enterocolitis and its timing with retinopathy of prematurity. Am J Perinatol. 2021.
Malviya MN, Ohlsson A, Shah SS. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2013.
Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatr. 2007;119:1165–74.
Lee J, Dammann O. Perinatal infection, inflammation, and retinopathy of prematurity. Semin Fetal Neonatal Med. 2012;17:26–9.
Silveira RC, Fortes Filho JB, Procianoy RS. Assessment of the contribution of cytokine plasma levels to detect retinopathy of prematurity in very low birth weight infants. Invest Ophthalmol Vis Sci. 2011;52:1297–301.
Jang JH, Kim JG, Lee YH, Bae JG, Park JH. The association between amniotic fluid-derived inflammatory mediators and the risk of retinopathy of prematurity. Medicine. 2022;101.
Laughon M, O’Shea MT, Allre EN, Bose C, Kuban K, Van Marter LJ, et al. Chronic lung disease and developmental delay at 2 years of age in children born before 28 weeks’ gestation. Pediatrics. 2009;124:637–48.
Lad EM, Hernandez-Boussard T, Morton JM, Moshfeghi DM. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am J Ophthalmol. 2009;148:451–8.
Söderström F, Normann E, Holmström G, Larsson E, Ahlsson F, Sindelar R, et al. Reduced rate of treated retinopathy of prematurity after implementing lower oxygen saturation targets. J Perinatol. 2019;39:409–14.
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, et al. European consensus guidelines on the management of respiratory distress syndrome–2019 update. Neonatology. 2019;115:432–50.
Funding
The Israel National VLBW infant database is partially funded by the Israel Ministry of Health and the Israel Center for Disease Control.
Author information
Authors and Affiliations
Consortia
Contributions
RS cleaned and analysed the data and drafted and revised the paper, TS collected the data and revised the paper, IZP wrote the statistical analysis plan and analysed the data and revised the paper, LLG analysed the data and revised the paper, BR cleaned and analysed the data, wrote the statistical analysis plan and revised the paper, TWJ initiated the project, collected and analysed the data, and revised the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study was conducted in accordance with prevailing ethical principles and approved by the Human Research Committee of the Sheba Medical Center (SMC-9443-22).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
The Israel Neonatal Network, which compiles the Israel national VLBW infant database, consists of these participating centers: Assaf Harofeh Medical Center, Rishon Le Zion; Assuta Hospital, Ashdod; Barzilay Medical Center, Ashkelon; Bikur Holim Hospital, Jerusalem; Bnei Zion Medical Center, Haifa; Carmel Medical Center, Haifa; English (Scottish) Hospital, Nazareth; French Hospital, Nazareth; Hadassah University Hospital Ein-Karem, Jerusalem; Hadassa University Hospital Har Hazofim, Jerusalem; Haemek Medical Center, Afula; Hillel Yafe Medical Center, Hadera; Italian Hospital, Nazareth; Kaplan Hospital, Rehovot; Laniado Hospital, Netanya; Maayanei Hayeshua Medical Center, Bnei-Brak; Meir Medical Center, Kefar Saba; Misgav Ladach Hospital, Jerusalem; Poriah Hospital, Tiberias; Rambam Medical Center, Haifa; Rivka Ziv Hospital, Zefat; Schneider Children’s Medical Center of Israel and Rabin Medical Center (Beilinson Campus), Petach- Tikva; Shaare-Zedek Hospital, Jerusalem; Sheba Medical Center, Tel-Hashomer; Soroka Medical Center, Beer-Sheva; Sourasky Medical Center, Tel-Aviv; Western Galilee Medical Center, Nahariya; Wolfson Medical Center, Holon; Yoseftal Hospital, Eilat; Coordinating center, The Women and Children’s Health Research Unit, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer.
Supplemental material is available at Eye’s website
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shemesh, R., Strauss, T., Zaslavsky-Paltiel, I. et al. Perinatal and neonatal risk factors for retinopathy of prematurity in very low birthweight, very preterm twins: a population-based study. Eye 38, 902–909 (2024). https://doi.org/10.1038/s41433-023-02801-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-023-02801-8